UA2

3,4-PYRROLIDINEDIOL,2-(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)-2S,3S,4R,5R

Created:	2006-08-23
Last modified:	2012-12-07

Find Related PDB Entry
2 entries where UA2 is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	34
Chiral Atom Count	4
Bond Count	36
Aromatic Bond Count	10

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3,4-PYRROLIDINEDIOL,2-(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)-2S,3S,4R,5R
Systematic Name (OpenEye OEToolkits)	(2S,3S,4R,5R)-2-(4-azanyl-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol
Formula	C₁₁ H₁₅ N₅ O₃
Molecular Weight	265.269
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	OC3C(c2c1ncnc(N)c1nc2)NC(CO)C3O
SMILES	CACTVS	3.370	Nc1ncnc2c1[nH]cc2[CH]3N[CH](CO)[CH](O)[CH]3O
SMILES	OpenEye OEToolkits	1.7.6	c1c(c2c([nH]1)c(ncn2)N)C3C(C(C(N3)CO)O)O
Canonical SMILES	CACTVS	3.370	Nc1ncnc2c1[nH]cc2[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1c(c2c([nH]1)c(ncn2)N)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
InChI	InChI	1.03	InChI=1S/C11H15N5O3/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15)/t5-,7+,9-,10+/m1/s1
InChIKey	InChI	1.03	AMFDITJFBUXZQN-KUBHLMPHSA-N

Drug Info: DrugBank

DrugBank ID	DB11676
Name	Galidesivir
Groups	investigational
Description	Galidesivir is an adenosine analogue that has been investigated for use against Zaire Ebolavirus.[A191451] In animal studies, galidesivir was effective in increasing the survival rates from infections caused by various pathogens, including Ebola, Marburg, Yellow Fever and Zika viruses.[L12084] _In vitro_, it displayed broad-spectrum antiviral activity against various negative- and positive-sense RNA viruses,[A191622] including coronaviruses, filoviruses, and arenaviruses.[L12039,L12084] Phase 1 clinical trials have begun to determine the safety of this drug in humans.[L12042] Because of its activity against other coronaviruses, it may be studied as a potential therapy for COVID-19.
Synonyms	Galidesivirum Galidésivir Immucillin-A Immucillin A Galidesivir
Categories	Anti-Infective Agents Antiviral Agents Carbohydrates Experimental Unapproved Treatments for COVID-19 Glycosides Heterocyclic Compounds, Fused-Ring Nucleic Acids, Nucleotides, and Nucleosides Nucleosides Purine Nucleosides Purine-Nucleoside Phosphorylase, antagonists & inhibitors Purines Ribonucleosides
CAS number	249503-25-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
RNA-directed RNA polymerase L	MATQHTQYPDARLSSPIVLDQCDLVTRACGLYSSYSLNPQLRNCKLPKHI...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682